Zobrazeno 1 - 10
of 137
pro vyhledávání: '"Allopurinol hypersensitivity syndrome"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
I-Hung Chen
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 21, Iss 5, Pp 228-232 (2005)
A 62-year-old male was sent to the emergency room due to a high fever and generalized skin rash after taking allopurinol for 9 days. Physical examination was normal except for the generalized skin rash presenting with erythematous macules. Complete b
Externí odkaz:
https://doaj.org/article/ee5c6127bb394df091936138eb60c110
Autor:
Nigel Fleeman, Gerlinde Pilkington, Yenal Dundar, Kerry Dwan, Angela Boland, Rumona Dickson, Hameed Anijeet, Tom Kennedy, Jason Pyatt
Publikováno v:
Health Technology Assessment, Vol 18, Iss 40 (2014)
Background: The term chronic kidney disease (CKD) is used to describe abnormal kidney function (or structure). People with CKD have an increased prevalence of cardiovascular disease (CVD). Evidence is emerging that allopurinol may have a role to play
Externí odkaz:
https://doaj.org/article/ae6414442a11494ea2b81b317b3c08c5
Publikováno v:
Arthritis Care & Research. 74:161-162
We thank Dr Lai for their interest in our study (1). While we did not show a statistically significant link between the use of allopurinol and mortality in people with gout, we agree that Allopurinol Hypersensitivity Syndrome (AHS) is the most seriou
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
International Journal of Rheumatic Diseases. 20:1057-1071
Background Despite many studies suggesting an association between human leukocyte antigen (HLA)-B*5801 and allopurinol-induced toxic epidermal necrolysis (TEN) and Stevens-Johnsons syndrome (SJS), the evidence of association in different populations
Publikováno v:
Seminars in Arthritis and Rheumatism. 46:594-600
Objective Positive HLA-B*5801 carriers are at greater risk of experiencing rare but severe allopurinol hypersensitivity syndrome (AHS) [i.e., Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)]; however, HLA-B*5801 prevalence and A
Publikováno v:
Zeitschrift für Gerontologie und Geriatrie. 51:703-710
The treatment of gout is based on several principles. Symptom control and termination of the inflammatory process are important early goals, whereas the urate level should be lowered in the long term to prevent further gout attacks and complications.
Autor:
Murray L. Barclay, Lisa K. Stamp
Publikováno v:
Rheumatology (Oxford, England). 57(suppl_1)
Allopurinol hypersensitivity syndrome (AHS) is a severe and sometimes life-threatening adverse drug reaction. Although AHS is rare, the number of patients with gout requiring allopurinol is high, and there are sufficient overall cases of AHS to warra
Autor:
Lisa K. Stamp, Peter T. Chapman
Publikováno v:
Drugs & Aging. 31:777-786
Gout is increasingly seen in the elderly population, in large part due to physiological decline in renal function with age, and as a result of therapy for comorbidities, in particular the use of diuretic therapies for hypertension and congestive hear